Policy Brief Issue 21: The Life Saving Drug Program: Australia’s pathway to high-cost drugs

Home > News > Publications > Documents > Policy Brief > Policy Brief Issue 21: The Life Saving Drug Program: Australia’s pathway to high-cost drugs

Download Download 212

Views 355

Details

Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost drugs for rare diseases (DRD). This program, funded and administered by the Department of Health and Aged Care, permitted sponsors (often pharmaceutical companies) to apply for listing when their clinically effective DRD is rejected for PBS listing on the grounds of effectiveness.

See how it is done in this document.

Related Projects

Development of policy options to support reimbursement decision on high-cost health interventions in Thailand’s public healthcare system

Top

Policy Brief Issue 21: The Life Saving Drug Program: Australia’s pathway to high-cost drugs

Details

Related Projects

Menu

Follow Us On

Subscribe to our mailing list

HITAP เข้าสู่ระบบ

Policy Brief Issue 21: The Life Saving Drug Program: Australia’s pathway to high-cost drugs

Details

Related Projects

Menu

Follow Us On

Subscribe to our mailing list

Subscribe to our mailing list